Approaches to inverse-probability-of-treatment-weighted estimation with concurrent treatments

Journal of Clinical Epidemiology

Volumn 66, Issue 8 SUPPL.8, 2013, Pages

  Ellis, Alan R ^a   Brookhart, M Alan ^a,b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b IL   (United States)

Author keywords

Epidemiologic methods; Estimation; Models; Propensity score; Statistical; Statistics as topic

Indexed keywords

IRON; RECOMBINANT ERYTHROPOIETIN; TRANSFERRIN;

ANEMIA; ARTICLE; CEREBROVASCULAR ACCIDENT; COMORBIDITY; DIALYSIS; DRUG EXPOSURE; ELECTRONIC MEDICAL RECORD; FEMALE; FOLLOW UP; HEART INFARCTION; HEMODIALYSIS PATIENT; HUMAN; INFECTION; INVERSE PROBABILITY OF TREATMENT WEIGHT; IRON THERAPY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROBABILITY; RACE; RETROSPECTIVE STUDY; TREATMENT OUTCOME; VASCULAR ACCESS;

EPIDEMIOLOGIC METHODS; ESTIMATION; MODELS; PROPENSITY SCORE; STATISTICAL; STATISTICS AS TOPIC;

ANEMIA; CONFOUNDING FACTORS (EPIDEMIOLOGY); DRUG THERAPY, COMBINATION; EPIDEMIOLOGIC METHODS; ERYTHROPOIETIN; FERRIC COMPOUNDS; HEMATINICS; HUMANS; KIDNEY FAILURE, CHRONIC; MEDICARE; MYOCARDIAL INFARCTION; OUTCOME ASSESSMENT (HEALTH CARE); RECOMBINANT PROTEINS; RENAL DIALYSIS; STROKE; TRANSFERRIN; UNITED STATES;

EID: 84880240517     PISSN: 08954356     EISSN: 18785921     Source Type: Journal    
DOI: 10.1016/j.jclinepi.2013.03.020     Document Type: Article

References (24)

1. J.M. Robins, M.A. Hernan, and B. Brumback Marginal structural models and causal inference in epidemiology Epidemiology 11 2000 550 560 (Pubitemid 30660034)
2. K. Hirano, G. Imbens, and G. Ridder Efficient estimation of average treatment effects using the estimated propensity score Econometrica 71 4 2003 1161 1189
3. T. Sato, and Y. Matsuyama Marginal structural models as a tool for standardization Epidemiology 14 2003 680 686 (Pubitemid 40417015)
4. P.R. Rosenbaum, and D.B. Rubin The central role of the propensity score in observational studies for causal effects Biometrika 70 1 1983 41 55
5. M.A. Hernán, and J.M. Robins Estimating causal effects from epidemiological data J Epidemiol Community Health 60 2006 578 586 (Pubitemid 44032819)
6. T. Stürmer, S. Schneeweiss, M. Brookhart, K. Rothman, J. Avorn, and R. Glynn Analytic strategies to adjust confounding using exposure propensity scores and disease risk scores: nonsteroidal anti-inflammatory drugs and short-term mortality in the elderly Am J Epidemiol 161 2005 891 898 (Pubitemid 40577844)
7. D. Freedman, and R. Berk Weighting regressions by propensity scores Eval Rev 32 4 2008 392 409
8. G. Imbens, and J. Wooldridge Recent developments in the econometrics of program evaluation J Econ Lit 47 1 2009 5 86
9. R. Kilpatrick, D. Gilbertson, M.A. Brookhart, E. Polley, K. Rothman, and B.D. Bradbury Exploring large weight deletion and the ability to balance confounders when using inverse probability of treatment weighting in the presence of rare treatment decisions Pharmacoepidemiol Drug Saf 22 2013 111 121
10. M.I. Yilmaz, Y. Solak, A. Covic, D. Goldsmith, and M. Kanbay Renal anemia of inflammation: the name is self-explanatory Blood Purif 32 3 2011 220 225
11. S. Fishbane, and J.K. Maesaka Iron management in end-stage renal disease Am J Kidney Dis 29 1997 319 333 (Pubitemid 27106553)
12. A. Besarab, and D.W. Coyne Iron supplementation to treat anemia in patients with chronic kidney disease Nat Rev Nephrol 6 12 2010 699 710
13. U.C. Brewster Intravenous iron therapy in end-stage renal disease Semin Dial 19 2006 285 290 (Pubitemid 44091702)
14. J. Parkkinen, L. von Bonsdorff, S. Peltonen, C. Gronhagen-Riska, and K. Rosenlof Catalytically active iron and bacterial growth in serum of haemodialysis patients after i.v. iron-saccharate administration Nephrol Dial Transplant 15 2000 1827 1834
15. B. Halliwell, and J.M. Gutteridge Oxygen toxicity, oxygen radicals, transition metals and disease Biochem J 219 1 1984 1 14 (Pubitemid 14171443)
16. A. Martin-Malo, A. Merino, J. Carracedo, M.A. Alvarez-Lara, R. Ojeda, and S. Soriano Effects of intravenous iron on mononuclear cells during the haemodialysis session Nephrol Dial Transplant 27 2012 2465 2471
17. A. Sevanian, and P. Hochstein Mechanisms and consequences of lipid peroxidation in biological systems Annu Rev Nutr 5 1985 365 390
18. J.A. Berliner, and J.W. Heinecke The role of oxidized lipoproteins in atherogenesis Free Radic Biol Med 20 5 1996 707 727 (Pubitemid 26105783)
19. J. Himmelfarb, P. Stenvinkel, T.A. Ikizler, and R.M. Hakim The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia Kidney Int 62 5 2002 1524 1538 (Pubitemid 35286260)
20. USRDS 2009 Annual Data Report: Atlas of End-Stage Renal Disease in the United States 2009 US Renal Data System, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Bethesda, MD
21. Researcher's Guide to the USRDS Database: 2010 ADR Edition 2011 National Institutes of Health, NIDDK Bethesda, MD
22. R. Crump, V. Hotz, G. Imbens, and O. Mitnik Moving the goalposts: addressing limited overlap in the estimation of average treatment effects by changing the estimand Technical Working Paper 330 2006 National Bureau of Economic Research Cambridge, MA Available at http://www.nber.org/papers/t0330 Accessed August 10, 2012
23. M.J. van der Laan, and M.L. Petersen Causal effect models for realistic individualized treatment and intention to treat rules Int J Biostat 3 1 2007 1557 4679 10.2202/1557-4679.1022 http://www.degruyter.com/view/j/ijb.2007.3.1/ ijb.2007.3.1.1022/ijb.2007.3.1.1022.xml?format=INT Accessed March 2007
24. O. Bembom, and M. van der Laan Data-adaptive selection of the truncation level for inverse-probability-of-treatment-weighted estimators Paper 230 2008 U.C. Berkeley Division of Biostatistics Berkeley, CA Available at http://biostats.bepress.com/ucbbiostat/paper230 Accessed August 10, 2012